IPSO Ventures – one to watch – EPIC:IPS

In August all three Directors bought shares.


Total Market Capitalisation only about £1Million

Yesterdays announcement means there could be a review of the company’s value.


Contents of the link are copied below.


For immediate release                                                                             15 September 2011


EU grants approval for Buccolam®

IPSO Ventures plc (“IPSO”), the creator of commercial value from technology, is pleased to report that further to the announcement on 1st July 2011 regarding Therakind, IPSO’s portfolio company, and Buccolam® the European Commission has now granted approval for Buccolam® for the treatment of prolonged, acute, convulsive seizures in infants, toddlers, children and adolescents from 3 months to less than 18 years.

This approval has triggered a further milestone payment for Therakind.  Therakind is expected to also receive royalties on sales of this product as Viropharma is now able to actively market this product across Europe.

IPSO has a 36% shareholding in Therakind.

Further information, please contact:

IPSO Ventures plcNick Rodgers, Chief Executive Officer Tel: 020 7921 2990nick@ipsoventures.comwww.ipsoventures.com
Allenby Capital Limited(Nominated adviser and broker)Nick NaylorNick Athanas  Tel: 020 3328 5656

Company description

IPSO Ventures plc is a business creator and active investor in new technologies, principally in the renewable energy and healthcare sector. Its experienced management team focuses on adding commercial value to enable young companies to move forward rapidly.


Please see the financial disclaimer elsewhere on my blog, and take advice from professional advisers before investing in shares.


Update, it is worth noting that Ipso has several other subsidiary companies, or close allies mentioned on their website, Axilica, Medermica, Polyfect Solutions, IPSoL Energy and WildKnowledge.  Here’s the link.



Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s